Within that group, they’re aiming for an "accelerated" approval in people who’ve received prior systemic therapies, among ...

ACR was a key indicator of risk for mortality in RA with chronic renal insufficiency, predicting all-cause mortality better than eGFR.

People with chronic kidney disease, Type 2 diabetes or both were predicted to have elevated cardiovascular disease (CVD) risk 8 to 28 years sooner than someone without those conditions, according to a ...

Scientists conducted a simulation study to estimate the impact of cardiovascular-kidney-metabolic (CKM) syndrome on cardiovascular disease (CVD) risk prediction. The study found that adults with ...

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

The following is a summary of “Multi-scalar data integration decoding risk genes for chronic kidney disease,” published in the October 2024 issue of Nephrology by Ding et al. Chronic Kidney Disease ...

The interaction between the gut microbiome and metabolites may mediate the effects of exposure to per- and polyfluoroalkyl ...

For children with vesicoureteral reflux, recurrent urinary tract infections (UTIs) are associated with a decrease in estimated glomerular filtration rate (eGFR).

Three phase 3 trials of combinations including datopotamab deruxtecan for the treatment of non–small cell lung cancer are beginning.

The FDA rejected sotagliflozin 5 years ago for the same indication but for the broader population of adults with T1D, due to ...

Committee members said there was uncertainty around sotagliflozin in patients with kidney disease. The FDA is currently ...